DE1695689C3 - 3- (5-Nitro-2-thenylideneamino) oxazolidone (2) derivatives - Google Patents
3- (5-Nitro-2-thenylideneamino) oxazolidone (2) derivativesInfo
- Publication number
- DE1695689C3 DE1695689C3 DE19671695689 DE1695689A DE1695689C3 DE 1695689 C3 DE1695689 C3 DE 1695689C3 DE 19671695689 DE19671695689 DE 19671695689 DE 1695689 A DE1695689 A DE 1695689A DE 1695689 C3 DE1695689 C3 DE 1695689C3
- Authority
- DE
- Germany
- Prior art keywords
- nitro
- oxazolidone
- compound
- given
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- AKVRXCJOGQDXMO-UHFFFAOYSA-N [O-][N+](C1=CC=C(C=NN([CH-]OC2)C2=O)S1)=O Chemical compound [O-][N+](C1=CC=C(C=NN([CH-]OC2)C2=O)S1)=O AKVRXCJOGQDXMO-UHFFFAOYSA-N 0.000 title 2
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 210000003754 fetus Anatomy 0.000 claims description 3
- -1 nitrofuran compound Chemical class 0.000 claims description 3
- 241000224526 Trichomonas Species 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 241000699670 Mus sp. Species 0.000 claims 2
- 231100000517 death Toxicity 0.000 claims 2
- 230000034994 death Effects 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000699800 Cricetinae Species 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 241000108056 Monas Species 0.000 claims 1
- 241001502500 Trichomonadida Species 0.000 claims 1
- 238000009395 breeding Methods 0.000 claims 1
- 230000001488 breeding effect Effects 0.000 claims 1
- 239000003337 fertilizer Substances 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 231100000518 lethal Toxicity 0.000 claims 1
- 230000001665 lethal effect Effects 0.000 claims 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical class NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 claims 1
- 229960001907 nitrofurazone Drugs 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000004083 survival effect Effects 0.000 claims 1
- 231100000419 toxicity Toxicity 0.000 claims 1
- 230000001988 toxicity Effects 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
Description
p gende Ergebnisse erhalten:get the following results:
Η,Ν —Ν Ο (II) »5Η, Ν —Ν Ο (II) »5
Testverbindung Infektionsausmaß nach TagenTest compound extent of infection by days
in der R eine Morpholino- oder Piperidinogruppein which R is a morpholino or piperidino group
darstellt, kondensiert und gewünschtenfalls die 30 3_(5„Nitro-2-thenyl- 2,3 1,6 0,6 0,2 0,4
erhaltene Verbindung der allgemeinen Formell idenamino)-5-morphodurch
Behandlung mit einer anorganischen oder ]inomethyl-oxazoliorganischen
Säure in ein Salz überführt. don-(2)represents, condensed and, if desired, the 30 3_ (5 "Nitro-2-thenyl-2.3 1.6 0.6 0.2 0.4
obtained compound of the general formula idenamino) -5-morpho converted into a salt by treatment with an inorganic or] i no methyl-oxazoliorganischen acid. don- (2)
3. Arzneimittel, bestehend aus einer Verbindung3. Medicinal product consisting of a compound
gemäß Anspruch 1 und üblichen Trägerstoffen 35 N-(5-Nitro-2-furfu- 2,2 2,0 1,6 1,6 2,4
und/oder Verdünnungsmitteln und/oder Hilfs- ryliden)-3-aminostoffen.
5-methylmercapto-according to claim 1 and conventional carriers 35 N- (5-nitro-2-furfu 2.2 2.0 1.6 1.6 2.4
and / or diluents and / or auxiliary ryliden) -3-amino substances. 5-methylmercapto-
methyl-oxazolidon-(2)
(ausgelegte Unterlagen
4o des belgischen Patents
6 35 608)methyl-oxazolidone- (2)
(laid out documents
4 o of the Belgian patent
6 35 608)
Kontrollversuch 2,4 2,2 2,0 1,8 2,2Control experiment 2.4 2.2 2.0 1.8 2.2
Die Erfindung betrifft den in den Ansprüchen ge- Aus der Tabelle ist die signifikante Wirkung derThe invention relates to the in the claims from the table is the significant effect of
kennzeichneten Gegenstand. erfindungsgemäßen Verbindung (Beispiel 1) ersicht-marked object. compound according to the invention (Example 1) apparent
Die als Ausgangsverbindungen im erfindungsgemä- Hch. Die bekannte Vergleichsverbindung hat nur ge-The starting compounds in the invention Hch. The known comparison compound has only
ßeu Verfahren verwendbaren 3-Aminö-oxazolidon-(2)- ringe Aktivität.3-Amino-oxazolidone- (2) -ring activity that can be used as a method.
derivate der allgemeinen Formel II werden nach dem 50 Die akute Toxizität (Maus, oral, LD50) des d-Iso-derivatives of the general formula II are used after 50 The acute toxicity (mouse, oral, LD 50 ) of the d-iso-
in der US-PS 28 02 002 beschriebenen Verfahren her- mers der erfindungsgemäßen Verbindung beträgtin the US-PS 28 02 002 described method is her- mers of the compound according to the invention
gestellt. 897 mg/kg, des 1-Isomers 1449 mg/kg und der Ver-placed. 897 mg / kg, the 1-isomer 1449 mg / kg and the
Im erfindungsgemäßen Verfahren werden die Reak- gleitverbindung 4500 mg/kg,In the process according to the invention, the reactive slip compound 4500 mg / kg,
tionsteilnehmer bei Raumtemperatur in einem Lö- Die Beispiele erläutern die Erfindung,tion participants at room temperature in a solution The examples illustrate the invention,
sungsmittel, wie Alkohol, kurze Zeit zur Umsetzung 55solvents, such as alcohol, take a short time to react 55
gebracht. Das Rohprodukt fällt aus und wird abfil- ... . .brought. The crude product precipitates and is filtered off .... .
triert. Die Verbindung kann durch übliche Säure-Base- Beispiel ltriert. The compound can be prepared by the usual acid-base example l
Extraktion gereinigt und aus Lösungsmitteln, wie 3-(5-Nitro-2-thenylidenamino)-5-morpholino-Purified extraction and removed from solvents such as 3- (5-Nitro-2-thenylidenamino) -5-morpholino-
Acetonitril, Äthanol oder deren Gemische, umkristalli- methyl-oxazolidon-(2)Acetonitrile, ethanol or mixtures thereof, recrystalline methyl-oxazolidone- (2)
siert werden. 60be sated. 60
Zur Herstellung der Salze werden anorganische Eine Lösung von 8,1 g S-Amino-S-morpholino-Inorganic A solution of 8.1 g of S-Amino-S-morpholino-
Säuren, wie Salzsäure, Bromwasserstoffsäure oder methyl-oxazolidon-(2) in 120 ml Äthanol wird raschAcids such as hydrochloric acid, hydrobromic acid or methyl-oxazolidone- (2) in 120 ml of ethanol will quickly
Schwefelsäure, oder organische Säuren verwendet, wie und unter Rühren mit einer Lösung von 6,3 g 5-Nitro-Sulfuric acid, or organic acids used as and with stirring with a solution of 6.3 g of 5-nitro
Essigsäure, Fumarsäure, Weinsäure, Apfelsäure, Ma- 2-thiophencarboxaldehyd in 50 ml Äthanol versetzt,Acetic acid, fumaric acid, tartaric acid, malic acid, 2-thiophenecarboxaldehyde added in 50 ml of ethanol,
lonsäure, Bernsteinsäure oder Maleinsäure. 65 Die erhaltene Fällung wird abfiltriert und, in ver-ionic acid, succinic acid or maleic acid. 65 The precipitate obtained is filtered off and, in mixed
Die Verbindungen der Erfindung sind Antiparasitika dünnter Salzsäure gelöst. Nach der Filtration wird dasThe compounds of the invention are antiparasitic agents dissolved in dilute hydrochloric acid. After filtration, the
und haben antibakterielle Wirkung. Sie sind besonders saure Filtrat mit 5 %iger wäßriger Natriumcarbonat-and have an antibacterial effect. They are particularly acidic filtrate with 5% aqueous sodium carbonate
aktiv gegen Trichomonas foetus und Salmonellen- lösung alkalisch gemacht. Das erhaltene Produkt wirdactive against Trichomonas fetus and salmonella solution made alkaline. The product obtained will
abfiltriert und aus einer Mischung von Acetonitril und Äthanol umkristallisiert. Die reine Verbindung schmilzt bei 203 bis 2040C.filtered off and recrystallized from a mixture of acetonitrile and ethanol. The pure compound melts at 203 to 204 0 C.
Das Hydrochlorid wird durch Suspendieren der Base in Alkohol und Zugabe von konzentrierter Salzsäure hergestellt. Die erhaltene Fällung wird abfiltriert und umkristallisiert.The hydrochloride is made by suspending the Base prepared in alcohol and addition of concentrated hydrochloric acid. The precipitate obtained is filtered off and recrystallized.
Bei der Kondensation von 3-Amino-5-piperidinomethyl-oxazolidon-(2) mit S-Nitro-^-thiophencarboxaldehyd gemäß Beispiel 1 erhält man 3-(5-Nitro-2-thenylidenamino>5-piperidinomethyl-oxazolidon-(2), Fp. 270 bis 271° C (Zers.).The condensation of 3-amino-5-piperidinomethyl-oxazolidone- (2) with S-nitro- ^ - thiophenecarboxaldehyde according to Example 1 gives 3- (5-nitro-2-thenylideneamino> 5-piperidinomethyl-oxazolidone- (2) , M.p. 270-271 ° C (dec.).
Claims (2)
darstellt, und ihre Salze mit Säuren. *5 Ferner wurden Hamster intravagmal mit Tncho-of 400 mg / kg of the corresponding nitrofuran compound in which R a morpholino or piperidino group led to the death of all test animals
represents, and their salts with acids. * 5 Hamsters were also given intravagmally with
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54246066 | 1966-04-14 | ||
DES0108501 | 1967-02-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1695689C3 true DE1695689C3 (en) | 1976-12-02 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1445186C3 (en) | 3,3'-di-2-imidazolin-2-yl-carbanilide | |
DE2921660A1 (en) | 5-NITROIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND ANTIPROTOZONE AGENTS CONTAINING THESE COMPOUNDS | |
DE1695689C3 (en) | 3- (5-Nitro-2-thenylideneamino) oxazolidone (2) derivatives | |
DE1807165A1 (en) | 4h-1 3-benzothiazine-4-ones bronchodilators | |
DE2322486C2 (en) | as-Triazino [5,6-c] quinoline and its salts, processes for the preparation thereof and medicaments containing these compounds | |
DE1645906C3 (en) | 4 Phenyl 1 piperidin carboxamide, process for their production and pharmaceutical preparations containing them | |
DE1695689B2 (en) | 3- (5-NITRO-2-THENYLIDENAMINO) OXAZOLIDONE (2) DERIVATIVES | |
DE2128941A1 (en) | New derivatives of the 2 amino 5 chloro thiazole | |
DE1813918C3 (en) | 2-Hydroxymethyl-3-carboxamido-quinoxaline-M-di-N-oxides, a process for their preparation and antibacterial agents containing these compounds | |
DE1445446A1 (en) | Benzylpenicillin derivative and method of production | |
DE3310584C2 (en) | ||
DE1250828B (en) | Process for the preparation of the spasmolytically active 6,7,3 ', 4' - tetraethoxy-1-benzylidene-1,2,3,4 tetrahydroisoquinoline and its salts | |
DE2062055C3 (en) | Propanolamine derivatives, process for their preparation and pharmaceuticals containing them | |
DE1952800C3 (en) | 3,6-dimethyl-1,2,3,4,4a, 9a-hexahydro-gamma-carboline dihydrochloride | |
DE2534963A1 (en) | PIPERAZINO-PYRIMIDINE AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
DE2166270B2 (en) | Nicotinoylaminoethanesulfonyl-2amino-thiazole | |
DE2005104C2 (en) | 1-Alkyl-6,7-methylenedioxy-4 (1H) -oxocinnoline-3-carboxylic acids and process for their preparation | |
DE1941026C3 (en) | 6-square bracket on 2,2-dimethyl-4- (p-hydroxyphenyl) -5-oxo-1-imidazolinyl, square bracket on -penicHlansäure and process for their preparation | |
DE1241437B (en) | Process for the preparation of biguanide guanylhydrazone compounds | |
AT337199B (en) | PROCESS FOR THE PRODUCTION OF NEW, TRICYCLIC CONDENSED IMIDAZOLE DERIVATIVES | |
DE2338350A1 (en) | BETA (3,4-DIALKANOYLOXYPHENYL) LALANINE ESTER | |
DE1670059B2 (en) | 1-METHYL-1- (2'-PYRIDYLMETHYL) GUANIDINE | |
DE2521905A1 (en) | FUMARIC SALT OF 1-DIAETHYLAMINO-AETHYL-3-(P-METHOXYBENZYL)-1,2-DIHYDRO-QUINOXALIN-2-ONE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICALS CONTAINING THIS COMPOUND | |
DE2221281A1 (en) | Pyrazole derivatives and processes for their preparation | |
DE1470043C (en) | alpha guamdinobenzylpenicilhn and processes for its production |